Michael Lemus
Physician Assistant · Fresno, CANPI 1326355660
Payments from drug & device makers
Across 115 payments — averaging $19.40 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- E.r. Squibb & Sons, L.L.C.$396
- AbbVie$269
- Novo Nordisk$180
- GSK$118
- Organogenesis Inc.$118
- Amgen$96
- plus $1K from 29 others
What the payments were for
- Food & beverage$2,231100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| E.r. Squibb & Sons, L.L.C. | 35 | $396 |
| AbbVie | 11 | $269 |
| Novo Nordisk | 4 | $180 |
| GSK | 5 | $118 |
| Organogenesis Inc. | 1 | $118 |
| Amgen | 5 | $96 |
| Pharmacyclics LLC, An Abbvie Company | 4 | $88 |
| Exelixis Inc. | 4 | $75 |
| Johnson & Johnson(2 entities) | 4 | $72 |
| AstraZeneca | 4 | $70 |
| Medtronic | 2 | $66 |
| Pfizer | 4 | $65 |
| Lilly USA, LLC | 3 | $57 |
| Abbott | 2 | $54 |
| Novartis | 3 | $44 |
| Daiichi Sankyo Inc. | 2 | $39 |
| Bristol Myers Squibb | 1 | $39 |
| Esperion Therapeutics, Inc. | 2 | $33 |
| Boston Scientific | 1 | $31 |
| Exact Sciences | 2 | $31 |
| EMD Serono, Inc. | 1 | $29 |
| Seagen Inc. | 2 | $27 |
| Hologic Sales And Service, LLC | 1 | $24 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 1 | $23 |
| Lundbeck LLC | 1 | $22 |
| Boehringer Ingelheim | 1 | $21 |
| Morphosys, US Inc. | 1 | $20 |
| Regeneron Healthcare Solutions, Inc. | 1 | $19 |
| Epizyme, Inc. | 1 | $18 |
| Coherus Oncology, Inc. | 1 | $17 |
| Acrotech Biopharma Inc. | 1 | $16 |
| Gilead | 1 | $15 |
| Taiho Oncology, Inc. | 1 | $15 |
| Beigene USA, Inc. | 1 | $13 |
| Merck | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$2,231 in reported general payments places this provider in the 80th percentile of 10,423 physician assistant providers in California.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| TrulicityDulaglutide | 28 | $29,668 |
| EliquisApixaban | 25 | $28,399 |
| JanuviaSitagliptin Phosphate | 27 | $26,278 |
| FarxigaDapagliflozin Propanediol | 18 | $23,479 |
| TradjentaLinagliptin | 20 | $21,025 |
| OzempicSemaglutide | 13 | $19,260 |
| Breo ElliptaFluticasone/Vilanterol | 18 | $10,167 |
| Toujeo SolostarInsulin Glargine,hum.Rec.Anlog | 11 | $8,127 |
| VascepaIcosapent Ethyl | 11 | $6,306 |
| Advair HfaFluticasone Propion/Salmeterol | 15 | $5,356 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 150 | $4,294 |
| Fluticasone-SalmeterolFluticasone Propion/Salmeterol | 12 | $2,588 |
| Lantus SolostarInsulin Glargine,hum.Rec.Anlog | 25 | $2,316 |
| Atorvastatin Calcium | 242 | $2,263 |
| Levothyroxine Sodium | 166 | $1,701 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Lilly USA, LLCTrulicity | $57 | $29,66828 claims |
| PfizerEliquis | $65 | $28,39925 claims |
| MerckJanuvia | $12 | $26,27827 claims |
| AstraZenecaFarxiga | $70 | $23,47918 claims |
| Boehringer IngelheimTradjenta | $21 | $21,02520 claims |
| Novo NordiskOzempic | $180 | $19,26013 claims |
| GSKBreo Ellipta | $118 | $10,16718 claims |
| AbbVieSynthroid | $269 | $73117 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 10,423 physician assistant providers in California.
Other physician assistant in Fresno
- Brooke KutkaFresno$67K
- David BakerFresno$37K
- John QuigleyDowney$2.9M
- Andrea NguyenIrvine$1M
- Mikhail AlperMadera$889K
- Erin JensenUpland$716K
- Franklin ClineSacramento$458K
- Carla CrespoMarina del Rey$297K
- Katherine OsakiEl Centro$274K
- Shawna JonesFountain Valley$266K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.